Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114195711B reveals efficient palladium-catalyzed carbonylation for quinoline synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN119823040A reveals a novel Pd-catalyzed route for heterocyclic synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115260188B details cobalt-catalyzed carbonylation for tetrahydro-beta-carboline ketones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed synthesis offers cost reduction in fine chemical manufacturing. High-purity amide compounds with scalable production capabilities for global supply chains.
Novel palladium-catalyzed carbonylation method for high-purity quinolone intermediates. Offers significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN117164506B reveals efficient carbonylation route. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering safer conditions and broader substrate scope for API intermediates.
Patent CN107628964B enables mild carbonylation. Reduces cost and improves supply chain for pharma intermediates. High purity and scalable production.
Patent CN115260188A details a novel cobalt-catalyzed carbonylation for tetrahydro-beta-carbolinones, offering a cost-effective, scalable alternative to palladium methods for API intermediates.
Patent CN112125856A reveals a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering safer conditions and broader substrate scope for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed one-pot method for 2-CF3 quinazolinones. High yield, scalable process for API intermediates using cheap nitro compounds.
Patent CN114539198B reveals novel Pd-catalyzed route for amide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed thiocarbonylation for (iso)chroman thioesters. Avoids thiols, uses sulfonyl chlorides. Cost-effective pharma intermediate manufacturing.
Patent CN112898192B reveals a safe, one-pot carbonylation route for N-acyl indoles using solid CO sources, offering significant cost reduction in pharmaceutical intermediate manufacturing.